1-1 of 1
Authors: Xiaowen Liu
Sort by
Journal Article
Circulating KIM-1 is a minimally invasive biomarker correlated with treatment response to nivolumab in patients with metastatic renal cell carcinoma
Wenxin Xu and others
The Oncologist, Volume 28, Issue Supplement_1, September 2023, Page S2, https://doi.org/10.1093/oncolo/oyad216.004
Published: 23 August 2023
Advertisement
Advertisement